Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oleg Fedorov

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Future Medicinal Chemistry|August 1, 2014
What is the future of bromodomains in targeted drug development?Oleg Fedorov
Nature Chemical Biology|February 16, 2010
The (un)targeted cancer kinomeOleg Fedorov, Susanne Müller, Stefan Knapp
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2011
Kinase inhibitor selectivity profiling using differential scanning fluorimetryOleg Fedorov, Frank H Niesen, Stefan Knapp
Drug Discovery Today|May 1, 2007
Insights for the development of specific kinase inhibitors by targeted structural genomicsOleg Fedorov, Michael Sundström, Brian Marsden, et al.
Proteins|April 9, 2008
RhoB can adopt a Mg2+ free conformation prior to GEF bindingMeera Soundararajan, Andrew Turnbull, Oleg Fedorov, et al.
Cell Chemical Biology|December 20, 2016
CBP/p300 Bromodomains Regulate Amyloid-like Protein Aggregation upon Aberrant Lysine AcetylationHeidi Olzscha, Oleg Fedorov, Benedikt M Kessler, et al.
Journal of Medicinal Chemistry|August 14, 2020
DFG-1 Residue Controls Inhibitor Binding Mode and Affinity, Providing a Basis for Rational Design of Kinase Inhibitor SelectivityMartin Schröder, Alex N Bullock, Oleg Fedorov, et al.
Mabs|March 18, 2017
Development of a monoclonal anti-ADAMTS-5 antibody that specifically blocks the interaction with LRP1Salvatore Santamaria, Oleg Fedorov, John McCafferty, et al.
Chembiochem : a European Journal of Chemical Biology|July 29, 2009
Propionate analogues of zearalenone bind to Hsp90Markus Ugele, Florenz Sasse, Stefan Knapp, et al.
Lipid Insights|October 4, 2014
Stimulation of Hepatic Apolipoprotein A-I Production by Novel Thieno-Triazolodiazepines: Roles of the Classical Benzodiazepine Receptor, PAF Receptor, and Bromodomain BindingHerman J Kempen, Daniel Bellus, Oleg Fedorov, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Future Medicinal Chemistry|August 1, 2014
What is the future of bromodomains in targeted drug development?Oleg Fedorov
Nature Chemical Biology|February 16, 2010
The (un)targeted cancer kinomeOleg Fedorov, Susanne Müller, Stefan Knapp
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2011
Kinase inhibitor selectivity profiling using differential scanning fluorimetryOleg Fedorov, Frank H Niesen, Stefan Knapp
Drug Discovery Today|May 1, 2007
Insights for the development of specific kinase inhibitors by targeted structural genomicsOleg Fedorov, Michael Sundström, Brian Marsden, et al.
Proteins|April 9, 2008
RhoB can adopt a Mg2+ free conformation prior to GEF bindingMeera Soundararajan, Andrew Turnbull, Oleg Fedorov, et al.
Cell Chemical Biology|December 20, 2016
CBP/p300 Bromodomains Regulate Amyloid-like Protein Aggregation upon Aberrant Lysine AcetylationHeidi Olzscha, Oleg Fedorov, Benedikt M Kessler, et al.
Journal of Medicinal Chemistry|August 14, 2020
DFG-1 Residue Controls Inhibitor Binding Mode and Affinity, Providing a Basis for Rational Design of Kinase Inhibitor SelectivityMartin Schröder, Alex N Bullock, Oleg Fedorov, et al.
Mabs|March 18, 2017
Development of a monoclonal anti-ADAMTS-5 antibody that specifically blocks the interaction with LRP1Salvatore Santamaria, Oleg Fedorov, John McCafferty, et al.
Chembiochem : a European Journal of Chemical Biology|July 29, 2009
Propionate analogues of zearalenone bind to Hsp90Markus Ugele, Florenz Sasse, Stefan Knapp, et al.
Lipid Insights|October 4, 2014
Stimulation of Hepatic Apolipoprotein A-I Production by Novel Thieno-Triazolodiazepines: Roles of the Classical Benzodiazepine Receptor, PAF Receptor, and Bromodomain BindingHerman J Kempen, Daniel Bellus, Oleg Fedorov, et al.
Pageof 12